(Q40070060)

English

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit